Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient

11Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A case of severe hypersensitivity syndrome, triggered by carbamazepine in the presence of a concomitant active human herpes virus (HHV) 6 and 7 infection is described. To further understand the molecular mechanism of this adverse reaction, analyses of the genetic variants of human leukocyte antigen (HLA) and of the epoxide hydrolase gene (EPHX1), previously associated with carbamazepine hypersensitivity, were performed. A lymphocyte transformation test (LTT) was conducted in order to detect drug-specific lymphocytes. In the hypersensitive patient, 2 genetic factors previously associated with intolerance to carbamazepine were detected: the allele HLA-A*3101 and homozygosity for the variant allele of SNP rs1051740 in EPHX1. Drug-specific lymphocytes could be detected by LTT when the HHV was active (positive PCR for viral DNA and increased anti-HHV 6 IgG titer), but not when it was no longer active. In conclusion, we document a case of severe carbamazepine hypersensitivity triggered by viral reactivation in a patient presenting the interaction of 2 unfavorable genetic factors. Copyright © 2009 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Calligaris, L., Stocco, G., De Iudicibus, S., Marino, S., Decorti, G., Barbi, E., … Ventura, A. (2009). Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient. International Archives of Allergy and Immunology, 149(2), 173–177. https://doi.org/10.1159/000189202

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free